Abstract
Using non-medicinal oral contrast agents may aid safe delivery of magnetic resonance image-guided (MR-guided) radiotherapy by improving the ability to visualise and avoid excessive radiation dose to adjacent bowel/stomach. This scoping review aims to map the literature on non-medicinal oral contrasts used in upper-abdominal diagnostic or therapeutic magnetic resonance imaging (MRI) to find potential candidates for employing in MR-guided radiotherapy and identify gaps in knowledge for further study. A scoping review of non-medicinal oral contrast used in upper-abdominal MRI research followed a pre-defined protocol based on Arksey and O'Malley's framework. Data were charted and reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Scoping Reviews reporting guidelines. Forty-seven studies from 1955 screened abstracts were charted. Thirty-one distinct non-medicinal oral contrast were identified, used primarily to enhance tissue visualisation (89%) or observe motility (11%) in diagnostic studies. All studies reported to be predominantly quantitative; only 13% included participant experience via questionnaires and none used qualitative methods. No studies have examined the efficacy of non-medicinal oral contrasts in MR-guided radiotherapy planning or delivery. Non-medicinal oral contrasts have been extensively investigated in diagnostic MRI to enhance gastrointestinal visualisation and assess motility. However, non-medicinal oral contrasts have not been investigated in the context of radiotherapy planning and treatment. Qualitative evaluation of the patient experience of non-medicinal oral contrasts in magnetic resonance image-guided radiotherapy should be considered alongside studies quantifying the potential clinical benefit. This review summarises the properties of non-medicinal oral contrasts and identifies critical gaps in the current evidence, particularly the absence of qualitative research in this domain and the unexplored potential for their application in MR-guided radiotherapy planning and delivery.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have